Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EAAA India Alternatives is one of India's leading alternative asset management platforms focused on private investments. With an AUM of approximately INR 54,654 crore (~$6.5 billion), the firm specializes in private credit, real assets/infrastructure, and private equity strategies. It manages funds for global institutions and high-net-worth individuals/family offices across North America, Europe/Middle East/Africa (EMEA), Asia-Pacific and India. The company is preparing for an IPO expected in late 2025[1][3][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EAAA India Alternatives.